Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 156Lung Neoplasms 99Carcinoma, Non-Small-Cell Lung 61Extensive Stage Small Cell Lung Cancer 10Adenocarcinoma of Lung 7Parkinson Disease 4, Autosomal Dominant Lewy Body 5Carcinoma, Small Cell 5Adenocarcinoma, Bronchiolo-Alveolar 5Small Cell Lung Cancer Extensive Stage 4Drug-Related Side Effects and Adverse Reactions 4Small Cell Lung Cancer Limited Stage 3SCLC, Extensive Stage 3SCLC 3Recurrence 3Radiation Injuries 3Neoplasms 3Carcinoma, Ovarian Epithelial 3Thymoma 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2SCLC,Extensive Stage 2Ovarian Neoplasms 2Melanoma 2Limited Stage Small Cell Lung Cancer 2Kidney Neoplasms 2Extensive Small Cell Lung Cancer 2Carcinoma, Neuroendocrine 2Breast Neoplasms 2

Interventions

Injections 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Widespread Small Cell Lung Cancer × Etoposide × Thoracic × Clear all
NCT07009457 2025-07-04

Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 1 Recruiting
48 enrolled
Thoracic

Widespread Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡